Showing results (241-250 of 294) with videos related to

Sort By:
Pageof 30
Pharmacology, Biochemistry, and Behavior|June 23, 2001
Pharmacodynamic and receptor binding changes during chronic lorazepam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.
Biochemical Pharmacology|December 11, 1991
Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepineW R Galpern, L G Miller, D J Greenblatt, et al.
Pharmacology|January 1, 1989
Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine dispositionD J Greenblatt, M K Divoll, D R Abernethy, et al.
Biopharmaceutics & Drug Disposition|March 1, 1997
Alprazolam hydroxylation by mouse liver microsomes in vitro: the effect of age and phenobarbital inductionK P Charpentier, L L von Moltke, J W Poku, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Lorazepam and oxazepam kinetics in women on low-dose oral contraceptivesD R Abernethy, D J Greenblatt, H R Ochs, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopramL L von Moltke, D J Greenblatt, G M Giancarlo, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranololH R Ochs, D J Greenblatt, H Friedman, et al.
Journal of Clinical Pharmacology|March 1, 1997
Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitorsJ Schmider, D J Greenblatt, L L von Moltke, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placeboD J Greenblatt, B L Ehrenberg, J Gunderman, et al.
Pageof 30